RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Aurora, CO · Boulder, CO · +452 more sites
Clinical trials in Grand Junction, CO
19 recruiting studies have a site in or near Grand Junction, CO, Colorado.
Top conditions here
- Lung Cancer (5)
- Breast Cancer (4)
- Parkinson's Disease (3)
- Leukemia (2)
- Hypertension (1)
- Multiple Sclerosis (1)
- Prostate Cancer (1)
- Migraine (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 19 of 19 studies
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Aurora, CO · +1147 more sites
RecruitingPhase 3NCT06498635
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Sponsor: National Cancer Institute (NCI)
Denver, CO · Grand Junction, CO · Lafayette, CO · +278 more sites
RecruitingPhase 3NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Sponsor: Merck Sharp & Dohme LLC
Grand Junction, CO · +14 more sites
RecruitingPhase not listedNCT02071134
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Sponsor: Boston Scientific Corporation
Aurora, CO · Grand Junction, CO · +27 more sites
RecruitingPhase 3NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Sponsor: Merck Sharp & Dohme LLC
Denver, CO · Golden, CO · Grand Junction, CO · +46 more sites
RecruitingPhase 3NCT06966700
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sponsor: Merck Sharp & Dohme LLC
Denver, CO · Grand Junction, CO · +61 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Fort Collins, CO · Grand Junction, CO · Greeley, CO · +126 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Aurora, CO · Denver, CO · Edwards, CO · +56 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Aurora, CO · Colorado Springs, CO · +112 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Aurora, CO · Basalt, CO · Colorado Springs, CO · +106 more sites
RecruitingPhase 3NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Sponsor: Bristol-Myers Squibb
Grand Junction, CO · Westminster, CO · +54 more sites
RecruitingNot applicableNCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor: Natera, Inc.
Grand Junction, CO · +48 more sites
RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Aurora, CO · Denver, CO · Grand Junction, CO · +94 more sites
RecruitingPhase 2NCT07075718
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Sponsor: Glaukos Corporation
Grand Junction, CO · +2 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Aurora, CO · Colorado Springs, CO · +1223 more sites
RecruitingPhase 3NCT06686771
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Sponsor: Canadian Cancer Trials Group
Grand Junction, CO · +70 more sites
RecruitingNot applicableNCT04916990
Improving Care for Rural Patients With Solid Tumors
Sponsor: University of Colorado, Denver
Aurora, CO · Colorado Springs, CO · +11 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Aurora, CO · Boulder, CO · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.